Companies Dominating the Sequencing Reagents Market
- Thermo Fisher Scientific, Inc.
- Company Overview
- Business Planning
- Main Product Offerings
- Financial Execution
- Main Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Illumina, Inc.
- QIAGEN
- BGI
- Pacific Biosciences of California, Inc.
- F. Hoffmann-La Roche A.G.
- Oxford Nanopore Technologies
- Agilent Technologies, Inc.
- Fluidigm Corporation
- ArcherDX, Inc.
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
2025 Sequencing Reagents Market is estimated at USD 9 billion.
The global sequencing reagents market size was valued at over USD 7.93 billion in 2024 and is projected to grow at a robust CAGR of 16.8%, surpassing USD 59.71 billion by 2037.
North America is projected to amass USD 20.30 billion by 2037, driven by the region’s advanced healthcare system.
The major players in the market are Thermo Fisher Scientific, Inc., Illumina, Inc., QIAGEN, BGI, Pacific Biosciences of California, Inc., F. Hoffmann-La Roche A.G., Oxford Nanopore Technologies, Agilent Technologies, Inc., Fluidigm Corporation, ArcherDX, Inc., Myriad Genetics. Inc., Eurofins Scientific, Takara Bio Inc., Mitsui Information Co., Ltd.
